Framingham believe that UA is not as a risk factor for CVD. 15 However, the relationship between serum UA levels and the MetS remains controversial. 16, 17 In Iran, several studies have been conducted to examine this relationship, [18] [19] [20] [21] but they have often different methodology through subjects or study designs. Some studies took a wide range of people for age with different health status, 18 some only in adolescents, 19 some in patients with coronary artery disease or diabetes, 20, 21 and some just in the middle-aged healthy population. 22 Although, some studies have shown that UA or HUA is associated with MetS or some of its components, a large population-based study in elderly people may have different results. The reason is some restrictions for the use of UA as an indicator. First, the antioxidative characteristic of UA showed paradoxical value depending on blood concentration. 8 Second, UA concentration differed with sex. 23 Third, age may affect UA levels due to aging-related changes in purine metabolism. 23 Since the combination of HUA and MetS together in the elderly can endanger their health, controlling the level of UA can help improve the health of the elderly. Accordingly, we planned to present the status of UA and prevalence of HUA and their relationship to MetS in the Iranian elderly population. The study results can be helpful in the elderly care intervention programs.
Materials and Methods

Study Population
This population-based cross-sectional study was derived from the Amirkola Health and Aging Project (AHAP). It is an ongoing cohort study that has been started since 2011 in Amirkola city in the northern part of Iran. The total population of 60 years and over in Amirkola was estimated to be 2234. A total of 1616 people (73%) participated in the study. After excluding 56 participants due to missing data on UA level or MetS, 1560 remained in the study. Details of the procedure were published in a previous article. 24 The project was funded by the Vice-Chancellery of Research and Technology, Babol University of Medical Sciences (BUMS) for investigation of the geriatric medical problems such as falling, bone fragility and fractures, cognitive impairment and dementia, poor mobility and functional dependence. The baseline stage of this project was done in 2011 and 2012. The details of the recruitment of participants were described previously. 24 The AHAP study was approved by the Medical Ethics Committee of BUMS (MUBABOL.REC.1392.14) and informed consent was obtained from all the participants.
Measurements of Metabolic Syndrome
The MetS was defined according to the Iranian National Committee of Obesity criteria. 25 MetS was diagnosed when a person had three or more of the following components: waist circumference (WC) > 95 cm, systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥ 85 mm Hg, highdensity lipoprotein cholesterol (HDL -C) < 40 in men and < 50 in women, triglyceride (TG) ≥150, fasting blood glucose (FBG) ≥100 mg/dL, or being treated for low High-density lipoprotein cholesterol (HDL-C) or high blood pressure, TG, and FBG.
In the study, the diagnosis of hypertension was based on blood pressure measurement using the Omron manometer M3 intelligence model in lying position at 2 times using standard methods. Average values of these 2 measurements were considered as hypertension. WC was measured as the width between the bottom rib and the top of the hip of the participants using a metric measuring tape. Weight was measured using a Seca digital scale with minimum clothes, with an accuracy of 0.1 kg, and height was measured by stadiometer with an error of 0.5 cm. Body mass index (BMI) was calculated based on the formula, weight (kg) / [height (m)] 2 . To measure blood glucose and lipids, after a 12-hour overnight fast, venous blood was drawn and collected in the tubes containing ethylenediaminetetraacetic acid to obtain centrifuged plasma. FBG and lipid profile were measured enzymatically by auto-analyzers. The sampling was done by skilled nurses and analyzed by clinical laboratory experts of Shahid Beheshti hospital of Babol, affiliated to BUMS, Iran.
Measurements of Uric Acid
The UA was determined on a standard autoanalyzer with Uricase and reagent Parsazmun Co, Tehran, Iran). Levels of UA were created as follows: 4/5≥ mg/dL, 4/51-6 mg/dL, 6/01-7 mg/dL, and ˃7 mg/dL. HUA is defined as an abnormally high level of UA in the serum. In adults, the normal rate is considered more than 6 mg/dL in women and 7 mg/dL in men. 26 
Statistical Analysis
In the present analysis, the key risk factor was MetS and its components, and the outcome was UA levels and HUA. Normality of variables of interest was tested by Kolmogorov-Smirnov. χ 2 and Fisher exact test were used for qualitative variables and ANOVA test for quantitative comparisons.
The relationship between UA and MetS was investigated in three aspects. First, the association between HUA and MetS was investigated in the whole population and based on sex. Then, the relationship between UA levels and MetS components was separately analyzed. Finally, the correlation between HUA and UA levels and MetS was investigated using crude and sex/age-adjusted multiple regression logistic models.
Statistical analysis was performed using SPSS version 18 software (SPSS Inc., Chicago, IL). The two-tailed P value less than 0.05 were considered significant.
Results
Descriptive Analysis 1560 people participated in the study. A total of 699 (44.7%) participants were female. The mean age was 68.5 ± 6.90 years for women and 69.9 ± 7.61 years for men. Table 1 shows the clinical and biochemical characteristics of the elderly population by gender. The prevalence of MetS was 74.36% (n = 1160) with higher prevalence in women than in men (85.7% vs. 65.1%; P < 0.001). As well as the prevalence of HUA was 5.5% in the population including 3.13% in men and 8.44% in women and it was significantly higher in women than in men (P < 0.001).
Acid Uric and Metabolic Syndrome Relationship
The association between HUA and the prevalence of MetS in the elderly general population had no significant difference, but it showed a significant relationship in both genders (P = 0.026, in men, and in women (P = 0.031; Table 2 ).
The relationship of MetS components with UA levels are shown in Table 3 . FBG showed a significant relationship with levels of UA (P = 0.03). This means that with increasing levels of UA, the level of FBG also increased, but there was no significant relationship between other MetS components and UA levels.
Correlation between MetS and UA levels within a normal to high range and HUA in logistic models did not show any significant correlation in both crude and adjusted models for age and sex (Table 4 ). Figure 1 shows the association of means UA with MetS components number by gender in the elderly population. Mean UA level had no significant relationship with the increase in the number of MetS components in both genders.
Discussion
The correlation of UA levels and MetS components has yielded conflicting results; while some studies reported strong associations among these variables 11, 27, 28 others did not confirm any independent correlation based on multiple regression models. They suggested that this correlation might be gender-specific, limited to higher levels of UA, and limited to a number of MetS components. [29] [30] [31] [32] Similarly, some studies have concluded that the association is confounded by the relationship between UA and established CVD risk factors, including hypertension, obesity, hyperlipidemia, or diabetes mellitus. [33] [34] [35] These findings are consistent with our data which confirmed no correlation between UA/HUA levels and MetS diagnosis using a stepwise logistic regression model in the elderly population. In the present study, the level of UA showed only a significant relationship with FBG, while there was no association with other MetS components and also with the diagnosis of MetS. In support of this finding, Leyva et al study indicated that sensitivity and specificity of HUA for the diagnosis of the MetS were both below 60% in their study. They concluded that UA levels had no significant predictive power to detect significant MetS.
The role of UA in the diagnosis of MetS and related components was investigated in some earlier studies. In a cohort study conducted among the white male population, UA was found to be loaded on a factor also associated with plasma insulin, FBG, TG and BMI, but not with BP. 36 In the Community Health Study conducted in Miami among 26 nondiabetic men and 24 women, Donahue et al 37 identified a high UA loading on a factor associated with WC, dyslipidemia, insulin resistance, and BP. Hodge et al 38 in a study of nondiabetic Mauritians, indicated that UA was related to a BP factor among men, and not in women. Liou et al 39 study concluded that UA is aggregated with BMI, WC, FBG, Log TG, and HDL-C and loaded on the metabolic factor. According to our results, UA levels are associated with hyperglycemia. This finding is consistent with those obtained by Viazzi et al, 40 Liou et al 39 and Aguilar-Andrade et al. 41 , where the UA levels were identified as a powerful predictor of type 2 diabetes mellitus in primary hypertension, especially in women.
MetS includes a combination of different components and that the different combination of MetS risk factors has different effects on individuals' health. Meigs 42 reviewed a dozen studies investigating the underlying structure of MetS using factor analysis. They found that MetS was composed of 2-4 domains of phenotypes with the obesity-dyslipidemiahyperinsulinemia domain being its central feature. A separate factor for BP was loosely associated with the core feature. Also, Liou et al 39 identified 2 phenotype domains of MetS by factor analysis in the study; a metabolic factor explained onethird of variance, and a BP factor accounted for another 25% of the variance. They concluded that the contribution of UA as an additional MetS component to explain the total variance seems to be insignificant. They also indicated that the information on UA levels might not be an important factor for exploring the underlying MetS structure. In addition to the MetS main components, there are other factors playing an equally important role in HUA development. Such components include age, BMI, smoking, lifestyle, gender, genetic factors, reduction of endothelial function, increased C-reactive protein activity, which are also associated with HUA pathogenesis. Also, the interrelationship between these factors should not be ignored. Overall, different findings of various studies cannot suggest a consistent role for UA in MetS diagnosis across different study populations. The role of other important factors in the relationship between UA and MetS should not be ignored. These include the intensity of the disorder among Mets components, the disorder existing simultaneously in the MetS components, whether or not any drugs are taken, and the type of drug if any is being taken. The uricosuric effect of glycosuria in patients with diabetes and fasting hyperglycemia may result in reduced serum UA level in these patients. In addition, the use of antihypertensive agents, especially diuretics, is known to be associated with increased UA levels. 41 Another concept to explain the difference in results is to use different criteria to define MetS. In Taiwan, the 75 percentile value of WC among middle-aged men is around 88 cm. 43 Asian men with WC ≥90 cm are suggested to have abdominal obesity and to be at risk of comorbidities by the Asian obesity criteria. 44 By the recently revised ATP III recommendations, WC ≥90 cm was used in Liou et al study for the diagnosis of the MetS. 39 We used WC≥ 95 cm according to the Iranian National Committee of Obesity definition. 25 The final point is the presence of HUA as symptomatic or asymptomatic. In the studies, it has not been confirmed whether or not the treatment of asymptomatic HUA is effective in improving the treatment of MetS. Some studies do not recommend routine screening for asymptomatic HUA, since treatment does not change the progression of disorders attributed to HUA, such as MetS, diabetes, kidney disease, especially diabetic nephropathy, the most common cause of CKD. 45, 46 There is serious experimental and epidemiological evidence as well as a number of clinical trials to support a relationship of HUA to CKD, and that UA lowering treatment might forestall CKD progression. However, these studies were of limited duration and small study population. Therefore, definitive answers about the efficacy and safety of pharmacological treatment for asymptomatic HUA in CKD would only be provided using large randomized controlled trials (RCTs). Although there is important evidence that UA lowering drugs highly benefits treating asymptomatic HUA in the setting of CKD, unavailability of these RCTs makes the routine recommendation of these drugs unsubstantiated.
This hypothesis can also be generalized and inclusive for other complications attributed to HUA such as MetS. Although a strong relationship between HUA and MetS is established through animal and epidemiological studies, the potential pathophysiological mechanism through which UA contributes to this disease state is just starting to get clarified. It is apparent that further studies are required to fully understand the role(s) of UA in MetS. 46 indicates that although HUA is well recognized as a risk factor for atherosclerotic diseases such as myocardial infarction and stroke 35 its independent association with cardiometabolic risk factors remained controversial. 11, 47 Although the reduction in endothelial nitric oxide bioavailability by UA is likely to be involved, the precise biological mechanisms underlying the association between serum UA and the development of MetS remains unclear. Nitric oxide seems to play an important role in the development of insulin resistance. Its deficiency is believed to reduce blood flow to insulin-sensitive tissues i.e. skeletal muscle, liver, adipose tissue, leading to block the insulin action. 21, 48, 49 Furthermore, HUA reduces urinary UA excretion through the effect of insulin on urinary tubules leading to HUA. 50 Most of the recent studies conducted on the relationship between UA levels with MetS concluded that no causal relationship actually exists. These results may be explained by some limitations involved including the studies being observational with small sample size. Moreover, the role of insulin resistance, renin-angiotensin system, endothelial dysfunction and oxidative stress were not assessed in these studies.
Although, the relationship between UA levels and cardiovascular conditions has been studied by a number of researches since the 1960s, 47 the results remain controversial. Also, the association between MetS and UA levels ranging between normal to high has not been fully investigated. In addition, most studies were conducted primarily on adults and the institutionalized population. There are a limited number of studies focusing on the elderly population which has a higher prevalence of HUA and MetS, and are of higher risk of developing CVD events. Kuzuya et al evaluated the effect of aging on UA levels in a longitudinal study among a large Japanese population group. They showed that the UA serum level is affected by aging, genetic, environmental factors as well as aging-related hormonal changes. 33 Estrogen hormone plays an important role in the regulation of serum UA through the removal of more urate from the kidney, secondary to reabsorption. 27, 51, 52 The strengths and limitations of our study need to be addressed. This is a population-based cross-sectional study with strict training process and quality assurance programs. Amirkola is a small city located in the north of Iran, in the province of Mazandaran with a population of 26 232 residents. The significant characteristics of this city include the homogeneity of its residents' economical and residential status, and lifestyle. This conditions resulted in confounding bias reduction and results in reliability improvement. Our study's response rate was high with no statistically significant difference between participants who completed and those who did not complete the data. There are some limitations in this study which are needed to be considered. First, the nature of the cross-sectional study did not allow us to assess the temporal relationship. Also, in order to verify the results, a cohort study with follow-up data is required. Second, this study only included participants aged ≥60 years; therefore, findings may not be generalizable to young people.
Conclusions
In conclusion, UA levels and HUA were not associated with MetS in elderly people due to a few issues. First of all, UA can be related to the MetS components individually, without being associated with MetS diagnosis. Moreover, a number of MetS components and their disorder severity and whether or not medicine is being consumed for the disrupted component can all affect the end results. MetS can present with varying phenotypes, and this also affects its association with UA. Also, using various definitions for MetS is another reason. In this research, we used the Iranian National Committee of obesity definition for WC. The last point is the level of UA. Different studies used a normal range of UA, its elevated range or both. When utilizing elevated UA range, studies need to indicate if HUA was symptomatic or asymptomatic. This is because the treatment of asymptomatic HUA is not confirmed in MetS.
However, with various confounders included metabolic and nonmetabolic components in the association between MetS and UA, which in turn fits into an intricate web of feedbacks, and the inevitable limitations in our understanding of vascular physiology, the whole relationship remains to be determined. Therefore, well-design studies of cohort and clinical trials are needed to assess the association in the community elderly population.
